InsituGen

Dunedin, New Zealand

InsituGen is reinventing steroid hormone testing with the world's first low-cost test for the detection of androgen and estrogen bioactivity

$297K raised

Apr 2024

Seed

Top Investors

New Zealand Growth Capital PartnersEnterprise AngelsPacific ChannelAngel Investors MarlboroughBooster

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has InsituGen raised?

InsituGen has raised $297K in total funding. The most recent round was Seed. The last funding was announced in April 2024.

Who are InsituGen's investors?

InsituGen's investors include New Zealand Growth Capital Partners, Enterprise Angels, Pacific Channel, Angel Investors Marlborough, Booster.

Where is InsituGen headquartered?

InsituGen is headquartered in Dunedin, New Zealand.

What does InsituGen do?

InsituGen is reinventing steroid hormone testing with the world's first low-cost test for the detection of androgen and estrogen bioactivity

What stage is InsituGen at?

InsituGen is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2024.

MLA

"InsituGen — Funding & Investors." VCBacked, April 28, 2024, https://www.vcbacked.co/company/insitugen. Accessed June 4, 2026.

APA

VCBacked. (2024). InsituGen — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/insitugen

Wikipedia (cite web)

{{cite web |title=InsituGen — Funding & Investors |url=https://www.vcbacked.co/company/insitugen |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2024.